Subscribe to RSS
DOI: 10.1055/a-0801-8917
Optical Imaging Technology: A Useful Tool to Identify Remission in Cushing Disease After Surgery
Publication History
received 02 April 2018
accepted 08 November 2018
Publication Date:
02 January 2019 (online)
![](https://www.thieme-connect.de/media/hmr/201902/lookinside/thumbnails/2018-04-0131_10-1055-a-0801-8917-1.jpg)
Abstract
We recently reported the use of optical imaging technology to quantify facial plethora in endogenous Cushing syndrome (CS). In the present study, we studied a larger cohort of patients with Cushing disease (CD) and examined water content fraction as well as blood volume fraction as bio-optic markers for determining the efficacy of this methodology as a predictor of lasting remission after surgery for CS. We imaged 49 patients before and after transsphenoidal surgery (TSS) for Cushing disease (CD); 22 patients were also seen at 3–6 months, and 13 patients 12 months post-operatively. On all patients, we used multi-spectral imaging (MSI) to evaluate hemodynamic distributions as well as water content at a specific area of the face. We found a decrease in blood volume fraction after vs. before surgical treatment in the tested facial area in 37 of the 40 patients, as determined with biochemical markers (p<0.001). All patients that were followed up for up to 12 months showed the same decrease from preoperative values and they remained in remission from CD. We conclude that MSI can be used for the evaluation of remission from CD, at least in the immediate post-operative period and up to one year after surgery. The use of this technology can supplement biochemical and other testing for the evaluation of the various treatment modalities available for patients with CD.
Key words
cushing disease - optical imaging technology - bio-optic marker - facial plethora - serum cortisol - water content volumeSupplementary Material
- for this article is available online at http://www.thieme-connect.de/products.
- Supplementary Material
-
References
- 1 Melmed SWR. Williams textbook of endocrinology. 12th ed . Philadelphia, PA: Elsevier/Saunders; 2011
- 2 Greenberg MS. Handbook of neurosurgery. 7th ed. Stuttgart: Thieme Medical Publishers; 2010
- 3 Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing's syndrome. Lancet (London, England) 2015; 386: 913-927
- 4 Nieman L. Cushing's syndrome. Philadephia: WB Saunders; 2001
- 5 Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: An epidemiological approach. Clin Endocrinol 1994; 40: 479-484
- 6 Pivonello R, Faggiano A, Lombardi G, Colao A. The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin North Am 2005; 34: 327-339 viii
- 7 Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Fillippela M, MarzUllo P, Cerbone G, Siciliani M, Lombardi G. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999; 84: 2664-2672
- 8 Clayton RN, Raskauskiene D, Reulen RC, Jones PW. Mortality and morbidity in Cushing's disease over 50 years in stoke-on-trent, UK: Audit and meta-analysis of literature. J Clin Endocrinol Metab 2011; 96: 632-642
- 9 Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, Van Aken MO, Voormolen JH, Romijn JA. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2007; 92: 976-981
- 10 Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB. Transsphenoidal microsurgery for Cushing's disease: Initial outcome and long-term results. J Clin Endocrinol Metab 2004; 89: 6348-6357
- 11 Hassan-Smith ZK, Sherlock M, Reulen RC, Arlt W, Ayuk J, Toogood AA, Cooper MS, Johnson AP, Stewart PM. Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab 2012; 97: 1194-1201
- 12 Swearingen B, Biller BM, Barker 2nd FG, Katznelson L, Grinspoon S, Klibanski A, Zervas NT. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Int Med 1999; 130: 821-824
- 13 Lindholm J, Juul S, Jørgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jørgensen J, Kosteljanetz L, Kristensen L, Laurberg P, Schmidt K, Weeke J. Incidence and late prognosis of cushing’s syndrome: A population-based study1. J Clin Endocrinol Metab 2001; 86: 117-123
- 14 Steffensen C, Bak AM, Zøylner Rubeck K, Jørgensen JO. Epidemiology of cushing’s syndrome. Neuroendocrinology 2010; 92 (Suppl. 01) 1-5
- 15 Bolland MJ, Holdaway IM, Berkeley JE, Lim S, Dansfield WJ, Conglen JV, Croxson MS, Gamble GD, Hunt PJ, Toomath RJ. Mortality and morbidity in cushing’s syndrome in new zealand. Clin Endocrinol 2011; 75: 436-442
- 16 Valassi E, Santos A, Yaneva M, Toth M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfifer M, Feelders A, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharievia S, Lamberts SW, Tabarin A, Webb SM. ERCUSYN study group. The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 2011; 165: 383-392
- 17 National Institutes of Health OoRDR. Rare Diseases and Related Terms. 2012 http://rarediseases.info.nih.gov/RareDiseaseList.aspx?PageID_1 Accessed January 25, 2012
- 18 Broder MS, Neary MP, Chang E, Cherepanov D, Ludlam WH. Incidence of cushing's syndrome and cushing's disease in commercially-insured patients<65 years old in the United States. Pituitary 2015; 18: 283-289
- 19 McCance DR, Gordon DS, Fannin TF, Hadden DR, Kennedy L, Sherdian B, Atkinson AB. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. Clin Endocrinol 1993; 38: 79-86
- 20 Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, Savage MO, Afshar F, Besser GM. Transsphenoidal resection in Cushing's disease: Undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol 1993; 38: 73-78
- 21 Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of cushing's syndrome: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 1526-1540
- 22 Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Finding JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sorino N, Vance ML, Giustina A, Boscaro M. Diagnosis and complications of cushing's syndrome: A consensus statement. J Clin Endocrinol Metab 2003; 88: 5593-5602
- 23 Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet (London, England) 2006; 367: 1605-1617
- 24 Dimopoulou C, Schopohl J, Rachinger W, Buchfelder M, Honegegr J, Reincke M, Stala GK. Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: Care reality in the Munich Metropolitan Region. Eur J Endocrinol 2014; 170: 283-292
- 25 Alexandraki KI, Kaltsas GA, Isidori AM, Storr HL, Afshar F, Sabin I, Akker SA, Chew SL, Drake WM, Monson JP, Besser GM, Grossman AB. Long-term remission and recurrence rates in Cushing's disease: Predictive factors in a single-centre study. Eur J Endocrinol 2013; 168: 639-648
- 26 Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Cola A, Hermus AR, Hofland LJ, Kilbanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petherson S, Sonio N, Stalla GK, Swearingen B, Vance ML, Wass JAH, Boscaro M. Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement. J Clin Endocrinol Metab 2008; 93: 2454-2462
- 27 Afshari A, Ardeshirpour Y, Lodish MB, Gourgari E, Sinaii N, Keil M, Belyavaskaya E, Lyssikatos C, Chowdhry FA, Chernomordik V, Anderson AA, Mazzuchi TA, Gandjbakhche A, Stratakis CA. Facial plethora: Modern Technology for quantifying an ancient clinical sign and its use in cushing syndrome. J Clin Endocrinol Metab 2015; 100: 3928-3933
- 28 Vogel A, Chernomordik VV, Riley JD, Hassan M, Amyot F, Dasgeb B, Demos SG, Pursley R, Little RF, Yarchoan R, Tao AY, Gandjbakhche AH. Using noninvasive multispectral imaging to quantitatively assess tissue vasculature. Journal of Biomedical Optics 2007; 12: 051604
- 29 Kainerstorfer JM, Amyot F, Ehler M, Hassan M, Demos SG, Chernomordik VV, Hitzenberger CK, Gandjbakhche AH, Casale GR. Direct curvature correction for noncontact imaging modalities applied to multispectral imaging. In: SPIE; 2010; 14
- 30 Sachdeva S. Fitzpatrick skin typing: Applications in dermatology. Indian Journal of Dermatology,Nenereology and Leprology 2009; 75: 93-96
- 31 Pathak MA, Fanselow DL. Photobiology of melanin pigmentation: Dose/response of skin to sunlight and its contents. J Am Acad Dermatol 1983; 9: 724-733
- 32 Sandby-Moller J, Poulsen T, Wulf HC. Epidermal thickness at different body sites: Relationship to age, gender, pigmentation, blood content, skin type and smoking habits. Acta Dermato-venereologica 2003; 83: 410-413
- 33 Yudovsky D, Pilon L. Rapid and accurate estimation of blood saturation, melanin content, and epidermis thickness from spectral diffuse reflectance. Appl Opt 2010; 49: 1707-1719
- 34 Batista DL, Riar J, Keil M, Stratakis CA. Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics 2007; 120: e575-e586
- 35 Batista DL, Oldfield EH, Keil MF, Stratakis CA. Postoperative testing to predict recurrent Cushing disease in children. J Clin Endocrinol Metab 2009; 94: 2757-2765
- 36 Lodish MB, Sinaii N, Patronas N, Dalia L, Keil M, Samuel J, Moran J, Verma S, Popovic J, Stratakis CA. Blood pressure in pediatric patients with cushing syndrome. J Clin Endocrinol Metab 2009; 94: 2002-2008
- 37 Lindsay JR, Oldfield EH, Stratakis CA, Nieman LK. The postoperative basal cortisol and crh tests for prediction of long-term remission from cushing's disease after transsphenoidal surgery. J Clin Endocrinol Metab 2011; 96: 2057-2064
- 38 Keil MF. Quality of life and other outcomes in children treated for cushing syndrome. J Clin Endocrinol Metab 2013; 98: 2667-2678
- 39 Kainerstorfer JM, Amyot F, Ehler M, Hassan M, Demos SG, Chernomordik V, Hitzenberger CK, Gandjbackshe AH, Riley JD. Direct curvature correction for noncontact imaging modalities applied to multispectral imaging. J Biomed Optics 2010; 15: 046013
- 40 Lourakis MI. A brief description of the Levenberg-Marquardt algorithm implemented by levmar. Found Res Technol 2005; 4: 1-6
- 41 Groenendaal W, von Basum G, Schmidt KA, Hilbers PAJ, van Riel NAW. Quantifying the composition of human skin for glucose sensor development. J Diabetes Sci Technol 2010; 4: 1032-1040